Your browser doesn't support javascript.
loading
Melanocortin therapies to resolve fibroblast-mediated diseases.
Khodeneva, Natalya; Sugimoto, Michelle A; Davan-Wetton, Camilla S A; Montero-Melendez, Trinidad.
Affiliation
  • Khodeneva N; The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Sugimoto MA; The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Davan-Wetton CSA; The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
  • Montero-Melendez T; The William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Front Immunol ; 13: 1084394, 2022.
Article in En | MEDLINE | ID: mdl-36793548
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Melanocortins Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Melanocortins Limits: Humans Language: En Year: 2022 Type: Article